Free Newsletter
Register for our Free Newsletters
Newsletter
Zones
Analysis, Inspection and Laboratory
LeftNav
Assisted/Independent Living
LeftNav
Clinical and Nursing Equipment
LeftNav
Design and Manufacture of Medical Equipment
LeftNav
Diagnostics Equipment, Monitoring and Test
LeftNav
Education, Training and Professional Services
LeftNav
Health Education and Patient Management
LeftNav
Health Estates Management
LeftNav
Healthcare Support and Information Services
LeftNav
Hygiene and Infection Control
LeftNav
IT and Communications in Healthcare
LeftNav
Materials
LeftNav
Medical Device Technology
LeftNav
Research and Development
LeftNav
Safety and Security
LeftNav
View All
Other Carouselweb publications
Carousel Web
Defense File
New Materials
Pro Health Zone
Pro Health Zone
Pro Security Zone
Web Lec
Pro Engineering Zone
 
 
News

US FDA approves Gen-Probe’s Procleix Ultrio assay to screen donated blood for hepatitis B

Gen-Probe : 14 August, 2008  (New Product)
The US Food and Drug Administration (FDA) has approved Gen-Probe’s supplemental regulatory application to use the Procleix Ultrio assay to screen donated blood for the hepatitis B virus (HBV).
The FDA had previously approved the Assay to screen donated blood for HIV-1 and the hepatitis C virus (HCV).

The Assay is now approved to screen donated blood, plasma, organs and tissue for the three viruses in individual blood donations or in pools of up to 16 blood samples. The Assay may be run on the enhanced semi-automated Procleix system (eSAS) and on the fully automated, high-throughput Procleix Tigris system.

'Gaining full FDA approval of the Procleix Ultrio Assay is an important milestone for our blood screening business,' said Hank Nordhoff, Gen-Probe's chairman and chief executive officer. 'More importantly, demonstrating that the Assay intercepts HBV-infected blood donations that older tests miss is an important scientific finding that may help further safeguard the US blood supply. We are grateful to the blood screening centres that participated in the trials to demonstrate the utility of the assay.' The Procleix Ultrio Assay is manufactured by Gen-Probe and sold worldwide by Chiron, a Novartis business.

Based on the full approval of the Procleix Ultrio Assay on the Tigris system, Gen-Probe expects to record a $10 million milestone payment from Chiron as collaborative research revenue in its third-quarter financial results.
Bookmark and Share
 
Home I Editor's Blog I News by Zone I News by Date I News by Category I Special Reports I Directory I Events I Advertise I Submit Your News I About Us I Guides
 
   © 2012 ProHealthServiceZone.com
Netgains Logo